PFE · News · 20260903N

Comirnaty Regulatory Approval

PFIZER INC · 2026-09-03 · Importance 41 · Surprise 60

The FDA approved Pfizer and BioNTech’s XFG-adapted COMIRNATY vaccine for the 2026–2027 season. The formulation is intended for adults aged 65 and older and people aged 5–64 with high-risk underlying conditions. The updated vaccine targets the XFG variant and is expected to become available shortly, supporting Pfizer’s seasonal COVID-19 vaccine transition.

Key facts

• The FDA-approved XFG-adapted COMIRNATY formula is for adults 65 and older and individuals aged 5-64 with high-risk underlying conditions. source